Vorilhon C - Search Results

1

New-Onset Left Bundle Branch Block Induced by Transcutaneous Aortic Valve Implantation.

Massoullié G, Bordachar P, Ellenbogen KA, Souteyrand G, Jean F, Combaret N, Vorilhon C, Clerfond G, Farhat M, Ritter P, Citron B, Lusson JR, Motreff P, Ploux S, Eschalier R. Massoullié G, et al. Among authors: vorilhon c. Am J Cardiol. 2016 Mar 1;117(5):867-73. doi: 10.1016/j.amjcard.2015.12.009. Epub 2015 Dec 13. Am J Cardiol. 2016. PMID: 26742470 Review.

2

Optimized management of heart failure patients aged 80 years or more improves outcomes versus usual care: The HF80 randomized trial.

Vorilhon C, Jean F, Mulliez A, Clerfond G, Pereira B, Sapin V, Souteyrand G, Citron B, Motreff P, Lusson JR, Eschalier R. Vorilhon C, et al. Arch Cardiovasc Dis. 2016 Dec;109(12):667-678. doi: 10.1016/j.acvd.2016.02.013. Epub 2016 Nov 9. Arch Cardiovasc Dis. 2016. PMID: 27825591 Free article. Clinical Trial.

3

Low fibrosis biomarker levels predict cardiac resynchronization therapy response.

Massoullié G, Sapin V, Ploux S, Rossignol P, Mulliez A, Jean F, Marie PY, Merlin C, Pereira B, Andronache M, Motreff P, Chabin X, Sellal JM, Citron B, Lusson JR, Vorilhon C, Clerfond G, Bordachar P, Zannad F, Eschalier R. Massoullié G, et al. Among authors: vorilhon c. Sci Rep. 2019 Apr 15;9(1):6103. doi: 10.1038/s41598-019-42468-4. Sci Rep. 2019. PMID: 30988339 Free PMC article.

4

Is there benefit in optimising heart failure treatment in over-80 year-old patients? (HF-80 study): study protocol for a randomized controlled trial.

Eschalier R, Jean F, Pereira B, Monzy S, Vorilhon C, Mactoux V, Citron B, Sapin V, Motreff P, Lusson JR. Eschalier R, et al. Among authors: vorilhon c. Trials. 2012 Mar 6;13:25. doi: 10.1186/1745-6215-13-25. Trials. 2012. PMID: 22394464 Free PMC article. Clinical Trial.

5

Heart failure prognosis and management in over-80-year-old patients: data from a French national observational retrospective cohort.

Vorilhon C, Chenaf C, Mulliez A, Pereira B, Clerfond G, Authier N, Jean F, Motreff P, Citron B, Eschalier A, Lusson JR, Eschalier R. Vorilhon C, et al. Eur J Clin Pharmacol. 2015 Feb;71(2):251-60. doi: 10.1007/s00228-014-1794-7. Epub 2014 Dec 24. Eur J Clin Pharmacol. 2015. PMID: 25537794

6

Impact of clinical characteristics and management on the prognosis of unselected heart failure patients.

Eschalier R, Chenaf C, Mulliez A, Yalioua A, Clerfond G, Authier N, Vorilhon C, Citron B, Pereira B, Jean F, Souteyrand G, Motreff P, Eschalier A, Lusson JR. Eschalier R, et al. Among authors: vorilhon c. Cardiovasc Drugs Ther. 2015 Feb;29(1):89-98. doi: 10.1007/s10557-015-6572-y. Cardiovasc Drugs Ther. 2015. PMID: 25700624

7

Acute and Chronic Pheochromocytoma-Induced Cardiomyopathies: Different Prognoses?: A Systematic Analytical Review.

Batisse-Lignier M, Pereira B, Motreff P, Pierrard R, Burnot C, Vorilhon C, Maqdasy S, Roche B, Desbiez F, Clerfond G, Citron B, Lusson JR, Tauveron I, Eschalier R. Batisse-Lignier M, et al. Among authors: vorilhon c. Medicine (Baltimore). 2015 Dec;94(50):e2198. doi: 10.1097/MD.0000000000002198. Medicine (Baltimore). 2015. PMID: 26683930 Free PMC article. Review.

8

Impact of patient education on chronic heart failure in primary care (ETIC): a cluster randomised trial.

Vaillant-Roussel H, Laporte C, Pereira B, De Rosa M, Eschalier B, Vorilhon C, Eschalier R, Clément G, Pouchain D, Chenot JF, Dubray C, Vorilhon P. Vaillant-Roussel H, et al. Among authors: vorilhon c. BMC Fam Pract. 2016 Jul 19;17:80. doi: 10.1186/s12875-016-0473-4. BMC Fam Pract. 2016. PMID: 27436289 Free PMC article. Clinical Trial.

9

[Contribution of magnetic resonance imaging in diagnosis of pericardial mesothelioma: a case report].

Nana A, Vorilhon C, Adjtoutah D, Azarnoush K, Kissel V, Chabin X, Chailloux A, Belhakem A, Tixier V, Ferrier N, Croisille P, Long JL, Marcaggi X. Nana A, et al. Among authors: vorilhon c. Ann Cardiol Angeiol (Paris). 2012 Nov;61(5):370-4. doi: 10.1016/j.ancard.2012.08.024. Epub 2012 Aug 28. Ann Cardiol Angeiol (Paris). 2012. PMID: 22959437 French.

10

Percutaneous repair or medical treatment for secondary mitral regurgitation: outcomes at 2 years.

Iung B, Armoiry X, Vahanian A, Boutitie F, Mewton N, Trochu JN, Lefèvre T, Messika-Zeitoun D, Guerin P, Cormier B, Brochet E, Thibault H, Himbert D, Thivolet S, Leurent G, Bonnet G, Donal E, Piriou N, Piot C, Habib G, Rouleau F, Carrié D, Nejjari M, Ohlmann P, Saint Etienne C, Leroux L, Gilard M, Samson G, Rioufol G, Maucort-Boulch D, Obadia JF; MITRA-FR Investigators. Iung B, et al. Eur J Heart Fail. 2019 Dec;21(12):1619-1627. doi: 10.1002/ejhf.1616. Epub 2019 Nov 18. Eur J Heart Fail. 2019. PMID: 31476260 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page